Status:
NOT_YET_RECRUITING
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Lymphatic Reconstruction
Lymphadenectomy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Detailed Description
To examine if performing lymphovenous bypass (LVB) at the time of axillary lymph node dissection (ALND) or inguinal lymph node dissection (ILND) in the melanoma participant population impacts the peri...
Eligibility Criteria
Inclusion
- Participants greater than or equal to 18 years of age.
- Participants willing to participate.
- Participants able to complete informed consent.
- Participants with a diagnosis of Melanoma undergoing ALND or ILND.
Exclusion
- Participant staking anticoagulants within 7 days prior to surgery.
- Participants that are known to be pregnant at the time of surgery.
- Participants with BMI greater than 50.0
Key Trial Info
Start Date :
September 6 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06887205
Start Date
September 6 2026
End Date
September 1 2028
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030